NEOTHERAPEUTICS INC
10-Q, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: NEOTHERAPEUTICS INC, 10-Q, 2000-11-14
Next: HIGH EQUITY PARTNERS L P SERIES 88, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       9,102,919
<SECURITIES>                                 3,166,773
<RECEIVABLES>                                8,225,074
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            20,936,320
<PP&E>                                       4,982,575
<DEPRECIATION>                               1,694,390
<TOTAL-ASSETS>                              24,830,033
<CURRENT-LIABILITIES>                        6,587,241
<BONDS>                                      1,554,322
                                0
                                          0
<COMMON>                                    97,670,870
<OTHER-SE>                                (85,323,428)
<TOTAL-LIABILITY-AND-EQUITY>                24,830,033
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            32,620,651
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,188,585
<INCOME-PRETAX>                           (34,900,548)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (34,900,548)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (34,900,548)
<EPS-BASIC>                                   (3.69)
<EPS-DILUTED>                                   (3.69)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission